A phase 2 dose exploratory study of K-877
Phase 2
- Conditions
- Dyslipidemia
- Registration Number
- JPRN-jRCT2080221294
- Lead Sponsor
- Kowa Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 192
Inclusion Criteria
Dyslipidemia with high TG and low HDL-C
Exclusion Criteria
The subject who need to be taken any other anti lipidemic agent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TG percent change at the completion of treatment<br>Central laboratory test
- Secondary Outcome Measures
Name Time Method Percent changes of other lipid parameters at the completion of treatment<br>Central laboratory test